早期给予支链氨基酸颗粒。
Early administration of branched-chain amino acid granules.
机构信息
Department of Gastroenterology and Hepatology, Saiseikai Niigata Daini Hospital, Niigata 950-1104, Japan.
出版信息
World J Gastroenterol. 2012 Sep 7;18(33):4486-90. doi: 10.3748/wjg.v18.i33.4486.
Abstract
The effect of malnutrition on survival in patients with decompensated liver cirrhosis has not been well defined. Nutritional intervention with branched-chain amino acid (BCAA) can increase serum albumin concentration in patients with decompensated cirrhosis but its effects on survival are unclear. The BCAA to tyrosine ratio (BTR) is a surrogate marker (the normal range of BTR is between 4.41 and 10.05, and a Fischer's ratio of 1.8 corresponds to a BTR of 3.5) in patients with decompensated liver cirrhosis, and BCAA inhibits hepatic carcinogenesis in patients with compensated cirrhosis. This review discusses data regarding the effect of early administration of BCAA granules based on the ratio of BCAA to BTR on prognosis in patients with cirrhosis.
摘要
营养不良对失代偿期肝硬化患者生存的影响尚未明确。给予支链氨基酸（BCAA）的营养干预可以增加失代偿期肝硬化患者的血清白蛋白浓度，但对生存的影响尚不清楚。BCAA 与酪氨酸的比值（BTR）是失代偿期肝硬化患者的替代标志物（BTR 的正常范围为 4.41 至 10.05，Fischer 比值为 1.8 对应 BTR 为 3.5），BCAA 抑制代偿期肝硬化患者的肝致癌作用。本综述讨论了根据 BCAA 与 BTR 的比值早期给予 BCAA 颗粒对肝硬化患者预后影响的数据。
相似文献
1
Early administration of branched-chain amino acid granules.早期给予支链氨基酸颗粒。
World J Gastroenterol. 2012 Sep 7;18(33):4486-90. doi: 10.3748/wjg.v18.i33.4486.
2
Impact of the branched-chain amino acid to tyrosine ratio and branched-chain amino acid granule therapy in patients with hepatocellular carcinoma: A propensity score analysis.支链氨基酸与酪氨酸比值及支链氨基酸颗粒疗法对肝细胞癌患者的影响：一项倾向评分分析。
J Gastroenterol Hepatol. 2015 Sep;30(9):1412-9. doi: 10.1111/jgh.12954.
3
Easy clinical predictor for low BCAA to tyrosine ratio in chronic liver disease patients with hepatocellular carcinoma: Usefulness of ALBI score as nutritional prognostic marker.慢性肝脏疾病合并肝细胞癌患者低支链氨基酸/酪氨酸比值的简易临床预测因子：ALBI 评分作为营养预后标志物的效用。
Cancer Med. 2021 Jun;10(11):3584-3592. doi: 10.1002/cam4.3908. Epub 2021 May 7.
4
Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis.口服支链氨基酸颗粒对肝硬化患者无事件生存期的影响。
Clin Gastroenterol Hepatol. 2005 Jul;3(7):705-13. doi: 10.1016/s1542-3565(05)00017-0.
5
Comparison of the effect of BCAA granules on between decompensated and compensated cirrhosis.支链氨基酸颗粒对失代偿期和代偿期肝硬化疗效的比较。
Hepatogastroenterology. 2009 Nov-Dec;56(96):1719-23.
6
Evaluating response to nutritional therapy using the branched-chain amino acid/tyrosine ratio in patients with chronic liver disease.利用支链氨基酸/酪氨酸比值评估慢性肝病患者对营养治疗的反应。
J Clin Lab Anal. 1999;13(1):31-4. doi: 10.1002/(SICI)1098-2825(1999)13:1<31::AID-JCLA6>3.0.CO;2-Y.
7
8
Branched-chain amino acids as a protein- and energy-source in liver cirrhosis.支链氨基酸作为肝硬化中的蛋白质和能量来源。
Biochem Biophys Res Commun. 2004 Jan 9;313(2):405-9. doi: 10.1016/j.bbrc.2003.07.016.
9
Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.口服支链氨基酸颗粒可降低肝硬化患者肝细胞癌的发生率并提高无事件生存率。
Dig Dis. 2011;29(3):326-32. doi: 10.1159/000327571. Epub 2011 Aug 9.
10
Effect of oral supplementation with branched-chain amino acid granules in the early stage of cirrhosis.口服补充支链氨基酸颗粒剂在肝硬化早期的作用
Hepatol Res. 2004 Dec;30S:36-41. doi: 10.1016/j.hepres.2004.08.009. Epub 2004 Nov 10.
引用本文的文献
1
The Role of Branched-Chain Amino Acid Supplementation in Combination with Locoregional Treatments for Hepatocellular Carcinoma: Systematic Review and Meta-Analysis.支链氨基酸补充剂联合局部区域治疗在肝细胞癌治疗中的作用：系统评价与荟萃分析
Cancers (Basel). 2023 Feb 1;15(3):926. doi: 10.3390/cancers15030926.
2
Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseases.非抗糖尿病药物在慢性肝病中的治疗机制和有益作用。
Clin Mol Hepatol. 2022 Jul;28(3):425-472. doi: 10.3350/cmh.2022.0186. Epub 2022 Jul 1.
3
Improvement in the Amino Acid Imbalance in Hepatitis C Virus Infected Patients After Viral Eradication by Interferon Treatment.干扰素治疗根除丙型肝炎病毒后，丙型肝炎病毒感染患者氨基酸失衡的改善。
Hepat Mon. 2016 May 23;16(6):e35824. doi: 10.5812/hepatmon.35824. eCollection 2016 Jun.
4
Effect of branched-chain amino acids in patients receiving intervention for hepatocellular carcinoma.支链氨基酸对接受肝细胞癌干预治疗患者的影响。
World J Gastroenterol. 2014 Mar 14;20(10):2673-80. doi: 10.3748/wjg.v20.i10.2673.
5
Leucine-rich diet supplementation modulates foetal muscle protein metabolism impaired by Walker-256 tumour.富含亮氨酸的饮食补充可调节受Walker-256肿瘤损害的胎儿肌肉蛋白质代谢。
Reprod Biol Endocrinol. 2014 Jan 3;12:2. doi: 10.1186/1477-7827-12-2.
本文引用的文献
1
Branched-chain amino acids to tyrosine ratio value as a potential prognostic factor for hepatocellular carcinoma.支链氨基酸与酪氨酸比值作为预测肝细胞癌潜在的预后因素。
World J Gastroenterol. 2012 May 7;18(17):2005-8. doi: 10.3748/wjg.v18.i17.2005.
2
Branched-chain amino acid treatment before transcatheter arterial chemoembolization for hepatocellular carcinoma.经导管动脉化疗栓塞术治疗肝细胞癌前支链氨基酸治疗。
World J Gastroenterol. 2012 Mar 28;18(12):1379-84. doi: 10.3748/wjg.v18.i12.1379.
3
Late-evening snack with branched-chain amino acids improves liver function after radiofrequency ablation for hepatocellular carcinoma.夜间进食支链氨基酸可改善肝癌射频消融后的肝功能。
Hepatol Res. 2012 Jul;42(7):658-67. doi: 10.1111/j.1872-034X.2012.00969.x. Epub 2012 Mar 2.
4
Anti-hypoalbuminemic effect of branched-chain amino acid granules in patients with liver cirrhosis is independent of dietary energy and protein intake.支链氨基酸颗粒对肝硬化患者的低白蛋白血症的防治作用不依赖于饮食的能量和蛋白质摄入。
Hepatol Res. 2011 Nov;41(11):1027-35. doi: 10.1111/j.1872-034X.2011.00864.x. Epub 2011 Sep 22.
5
Oral branched-chain amino acid granules reduce the incidence of hepatocellular carcinoma and improve event-free survival in patients with liver cirrhosis.口服支链氨基酸颗粒可降低肝硬化患者肝细胞癌的发生率并提高无事件生存率。
Dig Dis. 2011;29(3):326-32. doi: 10.1159/000327571. Epub 2011 Aug 9.
6
Branched-chain amino acids as pharmacological nutrients in chronic liver disease.支链氨基酸作为慢性肝病的药物营养素。
Hepatology. 2011 Sep 2;54(3):1063-70. doi: 10.1002/hep.24412. Epub 2011 Jun 23.
7
Effect of Oral Supplementation with Branched-chain Amino Acid (BCAA) during Radiotherapy in Patients with Hepatocellular Carcinoma: A Double-Blind Randomized Study.放疗期间口服补充支链氨基酸（BCAA）对肝细胞癌患者的影响：一项双盲随机研究。
Cancer Res Treat. 2011 Mar;43(1):24-31. doi: 10.4143/crt.2011.43.1.24. Epub 2011 Mar 31.
8
Effects of branched-chain amino acid-enriched nutrient for patients with hepatocellular carcinoma following radiofrequency ablation: a one-year prospective trial.富含支链氨基酸的营养素对射频消融治疗后肝细胞癌患者的影响：一项为期一年的前瞻性试验。
J Gastroenterol Hepatol. 2010 Sep;25(9):1550-5. doi: 10.1111/j.1440-1746.2010.06306.x.
9
Prospective randomized controlled study of short-term perioperative oral nutrition with branched chain amino acids in patients undergoing liver surgery.肝手术患者围手术期短期口服支链氨基酸营养的前瞻性随机对照研究
Hepatogastroenterology. 2010 May-Jun;57(99-100):583-90.
10
Effect of a late evening snack using branched-chain amino acid-enriched nutrients in patients undergoing hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma.富含支链氨基酸的夜间加餐对接受肝动脉灌注化疗的晚期肝细胞癌患者的影响。
Hepatol Res. 2010 Jun;40(6):574-84. doi: 10.1111/j.1872-034X.2010.00665.x.
Zotero 插件